SER - Serina Therapeutics Inc.
Close
7.98
-0.020 -0.251%
Share volume: 3,785
Last Updated: Fri 30 Aug 2024 10:30:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.00
-0.02
-0.25%
Summary score
28%
Profitability
32%
Dept financing
25%
Liquidity
5%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
32.82%
Return on assets
-52.17%
Return on sales
-13639.13%
Return on invested capital
35.95%
Total debt ratio
353.44%
Debt ratio change over timeo
8.84%
Current Ratio
0.28%
Quick Ratio
0.28%
Cash Position Ratio
0.13%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
25.93%
Return on assets
-21.45%
Return on sales
-19312.28%
Return on invested capital
-9.13%
Total debt ratio
126.41%
Debt ratio change over timeo
-2.07%
Current Ratio
0.29%
Quick Ratio
0.29%
Cash Position Ratio
0.2%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
219.01%
Return on assets
-21.38%
Return on sales
-46420%
Return on invested capital
77.73%
Total debt ratio
139.69%
Debt ratio change over time
-1.43%
Current Ratio
0.64%
Quick Ratio
0.64%
Cash Position Ratio
0.62%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-47.99%
Return on assets
-227.15%
Return on sales
-28556.95%
Return on invested capital
-13.82%
Total debt ratio
884.08%
Debt ratio change over time
8.84%
Current Ratio
-0.54%
Quick Ratio
-0.54%
Cash Position Ratio
-0.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SER | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 32.82% | 13.79% | 34.47% | 7.43% |
| Return on assets | -52.17% | 2.76% | 3.15% | 5.62% |
| Return on sales | -13639.13% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 35.95% | 2.36% | 5.39% | 19.77% |
| Profitability | 49% | 42% | 63% | 69% |
| Total debt ratio | 353.44% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 8.84% | 308.97% | -6.99% | 1.18% |
| Dept financing | 26% | 31% | 6% | 2% |
| Current Ratio | 0.29% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.29% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.2% | 0.36% | 1.28% | 2.93% |
| Liquididy | 5% | 14% | 33% | 75% |
| Short-term ratios | SER | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 25.93% | 13.77% | 13.25% | 3.8% |
| Return on assets | -21.45% | 2.43% | 1.89% | 3.09% |
| Return on sales | -19312.28% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -9.13% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 59% | 57% | 79% |
| Total debt ratio | 126.41% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.07% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 43% | 18% | 5% |
| Current Ratio | 0.29% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.29% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.2% | 0.36% | 1.28% | 2.93% |
| Liquididy | 5% | 12% | 31% | 75% |